BRICHOS domain associated with lung fibrosis, dementia and cancer – a chaperone that prevents amyloid fibril formation?

Authors

  • Hanna Willander,

    1.  Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden
    2.  KI-Alzheimer’s Disease Research Center, NVS Department, Karolinska Institutet, Stockholm, Sweden
    Search for more papers by this author
  • Erik Hermansson,

    1.  KI-Alzheimer’s Disease Research Center, NVS Department, Karolinska Institutet, Stockholm, Sweden
    Search for more papers by this author
  • Jan Johansson,

    1.  Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden
    2.  KI-Alzheimer’s Disease Research Center, NVS Department, Karolinska Institutet, Stockholm, Sweden
    Search for more papers by this author
  • Jenny Presto

    1.  Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden
    2.  KI-Alzheimer’s Disease Research Center, NVS Department, Karolinska Institutet, Stockholm, Sweden
    Search for more papers by this author

J. Presto, KI-Alzheimer's disease research center, NVS department, Karolinska Institutet, Stockholm, Sweden
Fax: +46 8 585 836 10
Tel: +46 8 585 839 03
E-mail: jenny.presto@ki.se

Abstract

The BRICHOS domain was initially defined from sequence alignments of the Bri protein associated with familial dementia, chondromodulin associated with chondrosarcoma and surfactant protein C precursor (proSP-C) associated with respiratory distress syndrome and interstitial lung disease (ILD). Today BRICHOS has been found in 12 protein families. Mutations in the Bri2 and proSP-C genes result in familial dementia and ILD, respectively, and both these conditions are associated with amyloid formation. Amyloid is of great medical relevance as it is found in several major incurable diseases, like Alzheimer’s and Parkinson’s disease and diabetes mellitus. Work on recombinant BRICHOS domains and transfected cells indicate that BRICHOS is a chaperone domain that, during biosynthesis, binds to precursor protein regions with high β-sheet propensities, thereby preventing them from amyloid formation. Regions prone to form β-sheets are present in all BRICHOS-containing precursor proteins and are probably eventually released by proteolytic cleavage, generating different peptides with largely unknown bioactivities. Recombinant BRICHOS domains from Bri2 and proSP-C have been found to efficiently prevent SP-C, the amyloid β-peptide associated with Alzheimer’s disease, and medin, found in aortic amyloid, from forming amyloid fibrils. The data collected so far on BRICHOS raise several interesting topics for further research: (a) amyloid formation is a potential threat for many more proteins than the ones recognized so far in amyloid diseases; (b) amyloid formation of widely different peptides involves intermediate(s) that are recognized by the BRICHOS domain, suggesting that they have distinct structural similarities; and (c) the BRICHOS domain might be harnessed in therapeutic strategies against amyloid diseases.

Ancillary